TRIPTODUR CARE
"TRIPTODUR CARE" is a word mark owned by Debiopharm International SA, filed at the USPTO on May 2, 2025. It has been allowed and covers classes 35, 36, 44 and 45.
- Status
- Allowed
- Since June 16, 2026
- Filed
- May 2, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99167826
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 4 classes
Who owns TRIPTODUR CARE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Debiopharm International SA
Lausanne, Switzerland
Representative
Stephen Pachol
Nixon & Vanderhye P.C.
What the mark covers
The products and services TRIPTODUR CARE is filed for, grouped by Nice class.
Providing information relating to business administration guidance in the field of medication reimbursement programs and services
Providing information relating to patient support services in the nature of providing financial support to patients for the purpose of facilitating good health and affordability programs being financial administration of patient reimbursement programs, drug access, and financial administration guidance in the nature of medication reimbursement programs and services
Providing medical information relating to hormonal disorders and pharmaceuticals used to treat endocrine disorders indicated for the treatment of precocious puberty, in the nature of affordability programs being patient assistance programs to provide medicines at low or no cost to patients undergoing treatment for central precocious puberty, medicine access, and administration guidance
Providing information relating to patient support services in the nature of personal support services for patients, namely, emotional counseling and emotional support
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Application extension granted/receipt provided
- Application extension to response period - received
7 earlier steps on the official record.
About TRIPTODUR CARE
Who owns the trademark "TRIPTODUR CARE"?
The USPTO trademark "TRIPTODUR CARE" (application 99167826) is owned by Debiopharm International SA.
What is the status of "TRIPTODUR CARE"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull TRIPTODUR CARE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2abe-1448-72b5-8a72-c1168d24a6c8
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2abe-1448-72b5-8a72-c1168d24a6c8",
"object": "trademark",
"mark_text": "TRIPTODUR CARE",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99167826",
"filing_date": "2025-05-02",
"nice_classes": [
35,
36,
44,
45
],
"owners": [
{
"name": "Debiopharm International SA",
"entity_id": "ent_019eb70b-6800-7238-b5b7-dbed47364f61"
}
]
}